FORTIS Charts, Analysis and Tips

home > pharma-and-healthcare > hospitals-and-medical-services > fortis

Technical Analysis

Technical Strength: 7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 59.3. According to RSI analysis, fortis is strong. 7.0 FORTIS RSI Chart
MACD (?) MACD: 2.12 and Signal Line: -0.752. According to MACD analysis, fortis is technically strong. 8.0 FORTIS MACD Chart
Simple Moving Average (?) Price just got above it's 200-day simple moving average which is a positive signal. According to simple moving average analysis, fortis is in a uptrend. Support level is at 156. 9.0 FORTIS Simple Moving Average Chart
Exponential Moving Average (?) 20-day exponential moving average just got above it's 50-day exponential moving average which is a positive signal. Price just got above it's 200-day exponential moving average which is a positive signal. According to exponential moving average analysis, fortis is in a uptrend. Support level is at 154. 9.0 FORTIS Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.881. According to bollinger bands, fortis is technically strong. 7.0 FORTIS Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA FORTIS Fibonacci Retracement Chart
Average True Range (?) ATR: 13.6 NA FORTIS Average True Range Chart
Average Directional Index (?) ADX is 16.4 which means FORTIS is in a trading range and there is no trend. NA FORTIS Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
February 23, 2018
Open Price 144.55
High Price 167.4
Low Price 143.65
Close Price 159.95
Absolute Change 13.65
Percentage Change 9.33%
Weekly Change 16.3%
Monthly Change 3.96%
Yearly Change -18.2%
52-week high 228.95
52-week low 107.1
Corporate Actions
ExDate Purpose
September 16, 2016 ANNUAL GENERAL MEETING
September 18, 2014 Annual General Meeting
August 18, 2009 Rhts Eq 2:5 & 2 Wrnt:2 Eq
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.753
Confidence in Beta6.3%
Market Capital Rs. 7405.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. -2.5
TTM Price-to-Earnings (P/E) Ratio -64
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 February 2018: Deliverable Quantity:1.6e+07 NA FORTIS Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 February 2018: Daily Volatility:1.0641 NA FORTIS Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 February 2018: PCR_OI:0.849 PCR:0.784 NA FORTIS PCR Chart
Option Pain (?) 23 February 2018: Max Pain:159.95 NA FORTIS Option Pain Chart
Premium (?) 23 February 2018 Premium: 5.0 Futures OI:0 NA FORTIS Premium Chart
Option_MAX_OI (?) 23 February 2018: Price:159.95 Put with maximum OI:130.0 Call with maximum OI:200.0 NA FORTIS Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 28, 2018 161.1 59472000.0 16603.0 19721.0 159.95
April 26, 2018 161.35 406000.0 261.0 296.0 159.95
May 31, 2018 162.25 7000.0 2.0 2.0 159.95

Announcements

February 22, 2018 FortUpdatestis Healthcare Limited has informed the Exchange regarding 'Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received a Notice (Ref. No. TS/206/2013/45933/1529) under Section 206(1) of Companies Act, 2013, on February 21, 2018 from Registrar of Companies, Punjab & Chandigarh, seeking certain information and documents as mentioned therein to be submitted by March 3, 2018. The Company is in process of collating the said information and will be sharing the same in due course. The financial implication/ compensation/penalty and quantum of claims has not been referred in the aforesaid letter and hence cannot be ascertained.'.
February 20, 2018 The News Clarification Exchange had sought clarification from the Company with respect to news item captioned "SFIO probe against Fortis and Religare". The response from the Company is enclosed
See all Announcements

Board Meetings

Date Meeting Date Purpose
February 14, 2018 February 28, 2018 The Results Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held February 13, 2018, To, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and Half Year ended September 30, 2017 and for the quarter and Period ended December 31, 2017. The Company has now informed the Exchange that the meeting of the Board of Directors has now been Scheduled to be held on February 28, 2018, for approval of the un-audited financial results for the Quarters ended September 30, 2017 and December 31, 2017.
February 08, 2018 February 13, 2018 To, Results inter-alia, consider and approve the Un-Audited Financial Results for the quarter and Half Year ended September 30, 2017 and for the quarter and Period ended December 31, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 122.8 Rs. 133.2 Rs. 146.6 Rs. 157 Rs. 170.3 Rs. 180.8 Rs. 194.1